Anxiety and sleep disorders

Abstract

Anxiety disorders are widespread among patients of primary care physicians and are the cause of increased morbidity and access to healthcare. Anxiety is a reaction of the body to the effects of stress and is manifested by the development of psychovegetative syndrome. In the general population, 5 to 7% of people have clinically significant anxiety, and in the practice of primary care physicians, these disorders are detected in every fourth patient. Anxiety disorder contributes to the development of psychogenic somatic pathology and/or negatively affects the course of background disease. Most patients with anxiety disorders suffer from various sleep disorders. In general practice, the frequency of sleep disorders reaches 73%. Chronic sleep disorder can act as a stressor that contributes to the development of pathophysiological changes in the body and increases anxiety. The above determines the need for early detection of sleep disorders and its timely treatment. The current treatment strategy for patients with sleep disorders involves an individualized approach to insomnia therapy. The existing arsenal of drugs used to treat sleep disorders allows this principle to be applied taking into account concomitant diseases (including anxiety disorders). The choice of product is also determined by good tolerability, efficacy and high safety profile. The optimal drug that answers the above requirements is doxylamine succinate, which allows you to effectively stop both anxiety symptoms and sleep disorders. Due to its high safety profile, doxylamine succinate can be used in the treatment of insomnia in pregnant women. The release form determines the convenience of use and the possibility of selecting an individual dose of the drug.

Exploring People’s Anxiety-Related Concerns Raised on a Computer-Mediated Health Platform: Topic Modeling Analysis

“…Previous studies have discovered the link between sleep, dyskinesia, bipolar, cognitive, and somatic disorders and anxiety. Most patients suffering from anxiety disorders experience various sleep disorders: In general practice, the prevalence of sleep disorders amounts to 73% [44]. On the other hand, Chronic sleep disorder is a potential stressor that increases anxiety [44].…”

“…Most patients suffering from anxiety disorders experience various sleep disorders: In general practice, the prevalence of sleep disorders amounts to 73% [44]. On the other hand, Chronic sleep disorder is a potential stressor that increases anxiety [44]. Sleep disturbances, especially insomnia, display a high prevalence in anxiety disorders [45].…”

“…As a result, sleep disturbance is regarded as a diagnostic symptom for some anxiety disorders, such as generalized anxiety disorder (GAD) and posttraumatic stress disorder (PTSD), and complaints like insomnia or nightmares have even been integrated into the de nitions of some anxiety disorders, for example, GAD and PTSD [45]. As can be seen, it is imperative to detect sleep disorders as early as possible and treat them as timely as possible [44].…”

“…This causal association has been identi ed in previous studies. As a study argued, anxiety disorders contribute to the development of psychogenic somatic pathology [44]. Similarly, Bekhuis et al revealed a higher prevalence of all clusters of somatic symptoms in patients with anxiety disorders than in controls, and they also found that all types of anxiety disorders were independently associated with somatic symptoms [58].…”